个人简述:

本人一直致力于乳腺癌复发转移方面的研究。一直从事MT1-MMP在乳腺癌的复发转移中的作用机制的研究，特别是在淋巴管生成中作用的研究，已取得一定成绩，共发表相关文章20余篇，其中SCI论文3篇，作为课题负责人承担有关MT1-MMP研究的省级基金3项，作为主要参与者参加国家科技支撑计划项目1项，参与省级课题多项。

科研工作:

[1] Yao G, Cao L, Liu M, Chen L, Hu X, Ye C. Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines andor Taxanes. Chemotherapy. 201661(4):171-8.[2] Cao L, Yao GY, Liu MF, Chen LJ, Hu XL, Ye CS. Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials. PLoS One. 2015 Dec 3010(12).[3] Yao G, He P, Chen L, Hu X, Gu F,Ye C. MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis. Cancer Cell Int, 2013, 13(1): 98.[4] He X#, Yao G#, Li F, Li M,Yang X. Risk-Association of Five SNPs in TOX3LOC643714 with Breast Cancer in Southern China. Int J Mol Sci, 2014, 15(2): 2130-2141.